Jan 25, 2024 / 01:00PM GMT
Christoffer Rosenblad Xvivo Perfusion AB(publ)-CEO
Thank you so much, for that, and welcome to XVIVO's earnings call for the fourth quarter of 2023 as well as the full year '23. Today's presenters are me, Christoffer Rosenblad, I mean currently at the headquarter in Gothenburg, and our CFO, Kristoffer Nordstrom, who is in our -- in Philadelphia and living in the US currently. And with that, we go to the next slide, Slide 3, which is a glance on the Q4 financials. And I'm happy to report the improvement in all three business areas. The adjusted EBITDA was slightly lower than expected, and our CFO will get into the details later in the presentation.
For sales, it came in at a record SEK156 million. The gross margins are continuously improving also in Q4. I'm especially proud of the abdominal gross margin where we are closing into the 2027 strategic goal of 70% gross margin already now and show 69% during the quarter and 66% during the year.
But for avoidance of doubt, that abdominal growth is hampered by production capacity. It's still growing and growing expected.
Q4 2023 Xvivo Perfusion AB Earnings Call Transcript
Jan 25, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers